US Stock MarketDetailed Quotes

PTPI Petros Pharmaceuticals

Watchlist
  • 0.2944
  • -0.0177-5.67%
Close Dec 20 16:00 ET
  • 0.2600
  • -0.0344-11.68%
Post 20:01 ET
2.95MMarket Cap-0.08P/E (TTM)

Petros Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-5.87%1.58M
-28.71%1.42M
-44.84%1.39M
-2.83%5.82M
-145.64%-364.25K
214.88%1.67M
-52.37%1.99M
2.14%2.52M
-23.29%5.99M
192.04%798.1K
Operating revenue
-5.87%1.58M
-28.71%1.42M
-44.84%1.39M
-2.83%5.82M
-145.64%-364.25K
214.88%1.67M
-52.37%1.99M
2.14%2.52M
-23.29%5.99M
192.04%798.1K
Cost of revenue
-29.74%287.01K
-35.95%329.11K
-39.75%331.83K
-28.75%1.63M
-82.06%158.15K
42.56%408.48K
-20.85%513.86K
16.60%550.74K
43.13%2.29M
261.60%881.33K
Gross profit
1.83%1.29M
-26.20%1.09M
-46.27%1.06M
13.19%4.19M
-527.65%-522.4K
172.59%1.27M
-58.16%1.48M
-1.28%1.97M
-40.39%3.7M
92.51%-83.23K
Operating expense
12.78%3.63M
-14.45%3.37M
52.15%4.99M
-23.50%14.95M
12.40%4.52M
-27.98%3.22M
-24.16%3.94M
-44.12%3.28M
-19.42%19.55M
-41.45%4.02M
Selling and administrative expenses
14.95%2.3M
1.65%2.29M
27.26%2.71M
-24.14%9.26M
-1.52%2.88M
-7.79%2M
-30.06%2.25M
-45.34%2.13M
-21.70%12.21M
-30.09%2.92M
Research and development costs
51.21%588.36K
-57.44%368.8K
387.62%1.56M
38.43%2.41M
369.35%834.33K
-47.13%389.09K
105.72%866.58K
-21.28%319.09K
-2.70%1.74M
-82.02%177.76K
Depreciation amortization depletion
-10.56%739.45K
-13.18%717.84K
-13.18%717.84K
-41.36%3.28M
-12.41%802.58K
-47.03%826.8K
-47.03%826.8K
-47.03%826.8K
-18.60%5.6M
-45.83%916.27K
-Depreciation and amortization
-10.56%739.45K
-13.18%717.84K
-13.18%717.84K
-41.36%3.28M
-12.41%802.58K
-47.03%826.8K
-47.03%826.8K
-47.03%826.8K
-18.60%5.6M
-45.83%916.27K
Operating profit
-19.89%-2.34M
7.39%-2.28M
-200.03%-3.93M
32.08%-10.76M
-22.86%-5.04M
68.58%-1.95M
-48.24%-2.46M
66.18%-1.31M
12.20%-15.85M
48.56%-4.1M
Net non-operating interest income expense
-323.30%-82.91K
105.82%4.88K
141.67%31.61K
96.42%-20.83K
177.83%101.77K
125.14%37.13K
44.22%-83.88K
50.43%-75.85K
-57.82%-581.82K
-1,009.26%-130.75K
Non-operating interest income
-55.00%75.82K
125.59%119.39K
128.93%151.82K
3,530.48%515.31K
1,503.42%227.59K
--168.48K
--52.92K
--66.32K
--14.19K
--14.19K
Non-operating interest expense
20.84%158.73K
-16.29%114.51K
-15.45%120.21K
-10.05%536.14K
-13.19%125.82K
-11.06%131.35K
-9.03%136.8K
-7.10%142.17K
61.67%596.02K
1,129.69%144.94K
Other net income (expense)
107.67%202K
1.61M
1.73M
172.58%2.62M
5.26M
64.68%-2.63M
-138.28%-3.61M
0
Gain on sale of security
-97.61%202K
--1.61M
--1.73M
2,880.22%13.71M
--5.26M
--8.45M
----
----
-95.12%460K
--0
Special income (charges)
----
----
----
--0
----
----
----
----
---7.46M
--0
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--7.46M
--0
Other non- operating income (expenses)
----
----
----
-427.11%-11.09M
--0
---11.09M
----
----
--3.39M
--0
Income before tax
51.19%-2.22M
74.00%-662.03K
-56.13%-2.16M
59.26%-8.16M
107.52%318.15K
67.08%-4.55M
-40.56%-2.55M
-695.04%-1.39M
-122.97%-20.04M
48.36%-4.23M
Income tax
0
0
0
0
0
0
0
0
0
-10.5K
Net income
51.19%-2.22M
74.00%-662.03K
-56.13%-2.16M
59.26%-8.16M
107.54%318.15K
67.10%-4.55M
-40.56%-2.55M
-695.04%-1.39M
-122.97%-20.04M
48.43%-4.22M
Net income continuous Operations
51.19%-2.22M
74.00%-662.03K
-56.13%-2.16M
59.26%-8.16M
107.54%318.15K
67.10%-4.55M
-40.56%-2.55M
-695.04%-1.39M
-122.97%-20.04M
48.43%-4.22M
Minority interest income
Net income attributable to the parent company
51.19%-2.22M
74.00%-662.03K
-56.13%-2.16M
59.26%-8.16M
107.54%318.15K
67.10%-4.55M
-40.56%-2.55M
-695.04%-1.39M
-122.97%-20.04M
48.43%-4.22M
Preferred stock dividends
210.02%1.05M
216.8K
595.51K
821.46K
482.22K
339.23K
Other preferred stock dividends
71.11%1.97M
1.86M
5.27M
4.83M
3.68M
1.15M
0
0
0
Net income attributable to common stockholders
13.17%-5.25M
-7.39%-2.73M
-479.50%-8.03M
31.06%-13.81M
9.03%-3.84M
56.31%-6.04M
-40.56%-2.55M
-695.04%-1.39M
-122.97%-20.04M
48.43%-4.22M
Basic earnings per share
81.40%-0.53
69.17%-0.37
-156.06%-1.69
34.40%-6.35
20.20%-1.62
57.40%-2.85
-36.36%-1.2
-725.00%-0.66
-17.33%-9.68
72.75%-2.03
Diluted earnings per share
81.40%-0.53
69.17%-0.37
-156.06%-1.69
34.40%-6.35
20.20%-1.62
57.40%-2.85
-36.36%-1.2
-725.00%-0.66
-17.33%-9.68
72.75%-2.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -5.87%1.58M-28.71%1.42M-44.84%1.39M-2.83%5.82M-145.64%-364.25K214.88%1.67M-52.37%1.99M2.14%2.52M-23.29%5.99M192.04%798.1K
Operating revenue -5.87%1.58M-28.71%1.42M-44.84%1.39M-2.83%5.82M-145.64%-364.25K214.88%1.67M-52.37%1.99M2.14%2.52M-23.29%5.99M192.04%798.1K
Cost of revenue -29.74%287.01K-35.95%329.11K-39.75%331.83K-28.75%1.63M-82.06%158.15K42.56%408.48K-20.85%513.86K16.60%550.74K43.13%2.29M261.60%881.33K
Gross profit 1.83%1.29M-26.20%1.09M-46.27%1.06M13.19%4.19M-527.65%-522.4K172.59%1.27M-58.16%1.48M-1.28%1.97M-40.39%3.7M92.51%-83.23K
Operating expense 12.78%3.63M-14.45%3.37M52.15%4.99M-23.50%14.95M12.40%4.52M-27.98%3.22M-24.16%3.94M-44.12%3.28M-19.42%19.55M-41.45%4.02M
Selling and administrative expenses 14.95%2.3M1.65%2.29M27.26%2.71M-24.14%9.26M-1.52%2.88M-7.79%2M-30.06%2.25M-45.34%2.13M-21.70%12.21M-30.09%2.92M
Research and development costs 51.21%588.36K-57.44%368.8K387.62%1.56M38.43%2.41M369.35%834.33K-47.13%389.09K105.72%866.58K-21.28%319.09K-2.70%1.74M-82.02%177.76K
Depreciation amortization depletion -10.56%739.45K-13.18%717.84K-13.18%717.84K-41.36%3.28M-12.41%802.58K-47.03%826.8K-47.03%826.8K-47.03%826.8K-18.60%5.6M-45.83%916.27K
-Depreciation and amortization -10.56%739.45K-13.18%717.84K-13.18%717.84K-41.36%3.28M-12.41%802.58K-47.03%826.8K-47.03%826.8K-47.03%826.8K-18.60%5.6M-45.83%916.27K
Operating profit -19.89%-2.34M7.39%-2.28M-200.03%-3.93M32.08%-10.76M-22.86%-5.04M68.58%-1.95M-48.24%-2.46M66.18%-1.31M12.20%-15.85M48.56%-4.1M
Net non-operating interest income expense -323.30%-82.91K105.82%4.88K141.67%31.61K96.42%-20.83K177.83%101.77K125.14%37.13K44.22%-83.88K50.43%-75.85K-57.82%-581.82K-1,009.26%-130.75K
Non-operating interest income -55.00%75.82K125.59%119.39K128.93%151.82K3,530.48%515.31K1,503.42%227.59K--168.48K--52.92K--66.32K--14.19K--14.19K
Non-operating interest expense 20.84%158.73K-16.29%114.51K-15.45%120.21K-10.05%536.14K-13.19%125.82K-11.06%131.35K-9.03%136.8K-7.10%142.17K61.67%596.02K1,129.69%144.94K
Other net income (expense) 107.67%202K1.61M1.73M172.58%2.62M5.26M64.68%-2.63M-138.28%-3.61M0
Gain on sale of security -97.61%202K--1.61M--1.73M2,880.22%13.71M--5.26M--8.45M---------95.12%460K--0
Special income (charges) --------------0-------------------7.46M--0
-Less:Impairment of capital assets --------------0------------------7.46M--0
Other non- operating income (expenses) -------------427.11%-11.09M--0---11.09M----------3.39M--0
Income before tax 51.19%-2.22M74.00%-662.03K-56.13%-2.16M59.26%-8.16M107.52%318.15K67.08%-4.55M-40.56%-2.55M-695.04%-1.39M-122.97%-20.04M48.36%-4.23M
Income tax 000000000-10.5K
Net income 51.19%-2.22M74.00%-662.03K-56.13%-2.16M59.26%-8.16M107.54%318.15K67.10%-4.55M-40.56%-2.55M-695.04%-1.39M-122.97%-20.04M48.43%-4.22M
Net income continuous Operations 51.19%-2.22M74.00%-662.03K-56.13%-2.16M59.26%-8.16M107.54%318.15K67.10%-4.55M-40.56%-2.55M-695.04%-1.39M-122.97%-20.04M48.43%-4.22M
Minority interest income
Net income attributable to the parent company 51.19%-2.22M74.00%-662.03K-56.13%-2.16M59.26%-8.16M107.54%318.15K67.10%-4.55M-40.56%-2.55M-695.04%-1.39M-122.97%-20.04M48.43%-4.22M
Preferred stock dividends 210.02%1.05M216.8K595.51K821.46K482.22K339.23K
Other preferred stock dividends 71.11%1.97M1.86M5.27M4.83M3.68M1.15M000
Net income attributable to common stockholders 13.17%-5.25M-7.39%-2.73M-479.50%-8.03M31.06%-13.81M9.03%-3.84M56.31%-6.04M-40.56%-2.55M-695.04%-1.39M-122.97%-20.04M48.43%-4.22M
Basic earnings per share 81.40%-0.5369.17%-0.37-156.06%-1.6934.40%-6.3520.20%-1.6257.40%-2.85-36.36%-1.2-725.00%-0.66-17.33%-9.6872.75%-2.03
Diluted earnings per share 81.40%-0.5369.17%-0.37-156.06%-1.6934.40%-6.3520.20%-1.6257.40%-2.85-36.36%-1.2-725.00%-0.66-17.33%-9.6872.75%-2.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.